Andrew Coop, Ph.D, associate dean of academic affairs and pharmacy professor at the University of Maryland School of Pharmacy, holds a container with dosages of a new kind of opioid, one that he says doesn't cause dependence. Drawn on the glass is the chemical structure for UMB24, the new kind of opioid.
Andrew Coop, Ph.D, associate dean of academic affairs and pharmacy professor at the University of Maryland School of Pharmacy, holds a container with dosages of a new kind of opioid, one that he says doesn't cause dependence. Drawn on the glass is the chemical structure for UMB24, the new kind of opioid. Algerina Perna TNS
Andrew Coop, Ph.D, associate dean of academic affairs and pharmacy professor at the University of Maryland School of Pharmacy, holds a container with dosages of a new kind of opioid, one that he says doesn't cause dependence. Drawn on the glass is the chemical structure for UMB24, the new kind of opioid. Algerina Perna TNS

More resources needed to battle the opioid epidemic

August 09, 2016 02:00 PM

UPDATED August 09, 2016 02:24 PM

More Videos

  • Seven things about Mizzou's declining enrollment

    The University of Missouri’s reputation, and enrollment, still reel from racial protests. Seven things about Mizzou's declining enrollment.